Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY.
Unniappan S, McIntosh CH, Demuth HU, Heiser U, Wolf R, Kieffer TJ.
Diabetologia · research support, non-u.s. gov't; journal article · DOI 10.1007/s00125-006-0310-8 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för [(R)-1-L-prolylpyrrolidin-2-yl]boronic acid. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
10 träffarRigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.
Engel M, Hoffmann T, Manhart S, Heiser U, Chambre S, Huber R, Demuth HU, Bode W.
J Mol Biol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jmb.2005.11.014Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs.
Shimazawa R, Takayama H, Kato F, Kato M, Hashimoto Y.
Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-894x(99)00034-7Inhibition of CD26 enzyme activity with pro-boropro stimulates rat granulocyte/macrophage colony formation and thymocyte proliferation in vitro.
Bristol LA, Bachovchin W, Takács L.
Blood · research support, non-u.s. gov't; journal article · DOI 10.1182/blood.v85.12.3602.bloodjournal85123602Solution structures of active and inactive forms of the DP IV (CD26) inhibitor Pro-boroPro determined by NMR spectroscopy.
Sudmeier JL, Günther UL, Gutheil WG, Coutts SJ, Snow RJ, Barton RW, Bachovchin WW.
Biochemistry · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1021/bi00207a009Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-lpr/lpr mice correlates with disease onset.
Kubota T, Iizuka H, Bachovchin WW, Stollar BD.
Clin Exp Immunol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1111/j.1365-2249.1994.tb06556.xPurified and cell-bound CD26: enzymatic inhibition, antibody binding profile, and expression on T cells in relation to other surface markers.
Scharpe S, De Meester I.
Verh K Acad Geneeskd Belg · research support, non-u.s. gov't; journal articleSeparation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition.
Gutheil WG, Bachovchin WW.
Biochemistry · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1021/bi00085a001Involvement of dipeptidyl peptidase IV in an in vivo immune response.
Kubota T, Flentke GR, Bachovchin WW, Stollar BD.
Clin Exp Immunol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1111/j.1365-2249.1992.tb06931.xInhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
Flentke GR, Munoz E, Huber BT, Plaut AG, Kettner CA, Bachovchin WW.
Proc Natl Acad Sci U S A · research support, u.s. gov't, p.h.s.; research-article; journal article · DOI 10.1073/pnas.88.4.1556